UB Paderborn / Katalog / Suche / in CDI

Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment, 2024-01, Vol.1058, p.168788, Article 168788

Nash, Kevin

2024

Link zum Volltext

Verfügbarkeit prüfen

Neuroinflammation and fractalkine signaling in Alzheimer's disease

Journal of neuroinflammation, 2019-02, Vol.16 (1), p.30-30, Article 30

2019

Link zum Volltext

Verfügbarkeit prüfen

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

The New England journal of medicine, 2024-02, Vol.390 (6), p.497-509

2024

Link zum Volltext

Verfügbarkeit prüfen

Nanomedicine in the ROS-mediated pathophysiology: Applications and clinical advances

Nanomedicine, 2015-11, Vol.11 (8), p.2033-2040

2015

Link zum Volltext

Verfügbarkeit prüfen

In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores

Gastroenterology (New York, N.Y. 1943), 2016-12, Vol.151 (6), p.1141-1154.e9

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients

Hepatology (Baltimore, Md.), 2013-11, Vol.58 (5), p.1644-1654

2013

Link zum Volltext

Verfügbarkeit prüfen

Pharmaceutical and Personal Care Products in Different Matrices: Occurrence, Pathways, and Treatment Processes

Water (Basel), 2021-05, Vol.13 (9), p.1159

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 523

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(464)
Mit Volltextzugriff
(481)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Distinct Gene Expression Profiles of Viral- and Nonviral-Associated Merkel Cell Carcinoma Revealed by Transcriptome Analysis

The KISS1 metastasis suppressor: mechanistic insights and clinical utility

Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis

Merkel Cell Carcinoma Dependence on Bcl-2 Family Members for Survival

BRMS1 Suppresses Breast Cancer Experimental Metastasis to Multiple Organs by Inhibiting Several Steps of the Metastatic Process

Requirement of KISS1 Secretion for Multiple Organ Metastasis Suppression and Maintenance of Tumor Dormancy

The diagnostic challenge of Hansen's disease

Nuclear magnetic resonance and circular dichroism study of metastin (Kisspeptin-54) structure in solution

An ASO therapy for Angelman syndrome that targets an evolutionarily conserved region at the start of the UBE3A-AS transcript

Abstract 126: The KISS1 metastasis suppressor appears to integrate glycolysis, mitochondrial biogenesis and metastasis via regulation of a PGC1α pathway

KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model

Abstract 3866: The KISS1 metastasis suppressor appears to reverse the Warburg effect by enhancing mitochondria biogenesis

Metastasis suppressor KISS1 appears to reverse the Warburg effect by enhancing mitochondrial biogenesis

Abstract 965: The KISS1 metastasis suppressor appears to reverse the ‘Warburg Effect’

Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO Study

KISS1 metastasis suppressor secretion is required for metastasis suppression

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma

The Phase-2 upgrade of the CMS outer tracker

Neuroinflammation and fractalkine signaling in Alzheimer's disease

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

Nanomedicine in the ROS-mediated pathophysiology: Applications and clinical advances

In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores

Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients

Pharmaceutical and Personal Care Products in Different Matrices: Occurrence, Pathways, and Treatment Processes

Suchergebnisse filtern